Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
GM3(O-acetyl-(N-glycolyl)neuraminic acid) + UDP-N-acetyl-D-galactosamine
UDP + N-acetyl-D-galactosaminyl-GM3(O-acetyl-(N-glycolyl)neuraminic acid)
-
Substrates: less effective substrate
Products: -
?
human glycoprotein hormone alpha-subunit + ?
glycosylated human glycoprotein hormone alpha-subunit + ?
-
Substrates: -
Products: -
?
UDP-galactose + p-nitrophenyl-GlcNAc
UDP + Gal-beta(1-4)GlcNAc-p-nitrophenyl
Substrates: 50% of activity with UDP-N-acetylgalactosamine
Products: -
?
UDP-GalNAc + 12-azidododecyl 5-(acetylamino)-3,5-dideoxy-beta-L-altro-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
UDP + 12-azidododecyl 2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-(acetylamino)-3,5-dideoxy-beta-L-altro-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
-
Substrates: -
Products: -
?
UDP-GalNAc + GlcNAcbeta1,3Fuc
UDP + GalNAcbeta1,4GlcNAcbeta1,3Fuc
-
Substrates: DNS-labeled acceptor substrate
Products: -
?
UDP-GalNAc + n-octyl-beta-D-glucopyranoside
UDP + GalNAcbeta(1-4)-glc-n-octyl
-
Substrates: -
Products: -
?
UDP-GalNAc + undec-10-enyl (5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
UDP + undec-10-enyl (5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->3)-[2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
-
Substrates: -
Products: -
?
UDP-GalNAc + undec-10-yn-1-yl 5-(acetylamino)-3,5-dideoxy-beta-L-altro-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
UDP + undec-10-yn-1-yl 2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-(acetylamino)-3,5-dideoxy-beta-L-altro-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
-
Substrates: -
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GD3
UDP + ganglioside GD2
Substrates: ganglioside GD3 i.e. 1-O-[O-(N-acetyl-alpha-neuraminyl)-(2->8)-O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]-ceramide
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3
UDP + ganglioside GM2
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 amide
UDP + ganglioside GM2 amide
Substrates: 10% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 methyl ester
UDP + ganglioside GM2 methyl ester
Substrates: 13% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3 methylamide
UDP + ganglioside GM2 methylamide
Substrates: 1% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside lyso-GM3
UDP + ganglioside lyso-GM2
Substrates: 28% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside N-acetyl-lyso-GM3
UDP + ganglioside N-acetyl-lyso-GM2
Substrates: 160% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside N-octanoyl-lyso-GM3
UDP + ganglioside N-octanoyl-lyso-GM2
Substrates: 122% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM3
UDP + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM2
Substrates: 102% of the activity with ganglioside GM3
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + GD3(N-acetylneuraminic acid)-ganglioside
UDP + GD2(N-acetylneuraminic acid)-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + GD3(N-glycolylneuraminic acid)-ganglioside
UDP + GD2(N-glycolylneuraminic acid)-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + lactosylceramide
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GA2
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
UDP-N-acetyl-D-galactosamine + GD3-ganglioside
UDP + GD2-ganglioside
UDP-N-acetyl-D-galactosamine + GM3(N-acetylneuraminic acid)-ganglioside
UDP + GM2(N-acetylneuraminic acid)-ganglioside
UDP-N-acetyl-D-galactosamine + GM3(N-glycolylneuraminic acid)-ganglioside
UDP + GM2(N-glycolylneuraminic acid)-ganglioside
UDP-N-acetyl-D-galactosamine + lactosylceramide
UDP + GA2-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + N-acetylneuraminelactose
UDP + N-acetyl-D-galactosaminyl-N-acetylneuraminelactose
-
Substrates: i.e. sialyllactose
Products: -
?
UDP-N-acetyl-D-galactosamine + SM3-ganglioside
UDP + SM2-ganglioside
-
Substrates: best substrate, no substrates are SM4-ganglioside, Gb3- and Gb4-ceramide
Products: -
?
UDP-N-acetylgalactosamine + GlcNAcbeta(1-3)GalNAcalpha-p-nitrophenol (core 3-p-nitrophenol)
UDP + GalNAcbeta(1-4)GlcNAcbeta(1-3)GalNAcalpha-p-nitrophenol
Substrates: 20% of activity compared with N-acetylglucosamine-beta-benzyl
Products: -
?
UDP-N-acetylgalactosamine + GlcNAcbeta(1-6)(Galbeta1-3)GalNAcalpha-p-nitrophenol (core 2-p-nitrophenol)
UDP + GalNAcbeta(1-4)GlcNAcbeta(1-6)(Galbeta1-3)GalNAcalpha-p-nitrophenol
Substrates: 15.2% of activity compared with N-acetylglucosamine-beta-benzyl
Products: -
?
UDP-N-acetylgalactosamine + GlcNAcbeta(1-6)GalNAcalpha-p-nitrophenol (core 6-p-nitrophenol)
UDP + GalNAcbeta(1-4)GlcNAcbeta(1-6)GalNAcalpha-p-nitrophenol
Substrates: 190.7% of activity compared with N-acetylglucosamine-beta-benzyl
Products: -
?
UDP-N-acetylgalactosamine + N-acetylglucosamine-beta-benzyl
N,N'-diacetyllactosediamine + benzol
Substrates: -
Products: formation of beta-1,4-linkage
?
UDP-N-acetylgalactosamine + p-nitrophenyl-GlcNAc
UDP + GalNac-beta(1-4)GlcNAc-p-nitrophenyl
Substrates: -
Products: -
?
UDP-N-acetylglucosamine + p-nitrophenyl-GlcNAc
UDP + GlcNAc-beta(1-4)GlcNAc-p-nitrophenyl
Substrates: 50% of activity with UDP-N-acetylgalactosamine
Products: -
?
additional information
?
-
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3
UDP + ganglioside GM2
Substrates: -
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3
UDP + ganglioside GM2
Substrates: ganglioside GM3 i.e. 1-O-[O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]-ceramide
Products: -
?
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3
UDP + ganglioside GM2
Substrates: ganglioside GM3 i.e. 1-O-[O-(N-acetyl-alpha-neuraminyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]-ceramideganglioside
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: from human spleen or rat liver
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
Substrates: i.e. GM3(N-acetylneuraminic acid), best substrate
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
Substrates: relative glycosyltransferase levels involved in determining the ganglioside composition of cells
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: 73%-78% as effective as GM3(N-glycolylneuraminic acid)
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: -
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: 73%-78% as effective as GM3(N-glycolylneuraminic acid)
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: from human spleen or rat liver
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: less effective: GM3(O-acetyl-(N-glycolyl)neuraminic acid)
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: i.e. GM3(N-acetylneuraminic acid), best substrate
Products: i.e. GM2(N-acetylneuraminic acid)-ganglioside
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: model for ganglioside biosynthesis
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: involved in biosynthesis of gangliosides in brain
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM3
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM3
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM2
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM2
Products: -
?
UDP-N-acetyl-D-galactosamine + GD3-ganglioside
UDP + GD2-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + GD3-ganglioside
UDP + GD2-ganglioside
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + GD3-ganglioside
UDP + GD2-ganglioside
-
Substrates: GD3(N-glycolylneuraminic acid): 66% as effective as GM3(N-glycolylneuraminic acid), GD3(N-acetylneuraminic acid): 76% as effective as GM3(N-glycolylneuraminic acid)
Products: -
?
UDP-N-acetyl-D-galactosamine + GD3-ganglioside
UDP + GD2-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + GM3(N-acetylneuraminic acid)-ganglioside
UDP + GM2(N-acetylneuraminic acid)-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + GM3(N-acetylneuraminic acid)-ganglioside
UDP + GM2(N-acetylneuraminic acid)-ganglioside
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + GM3(N-glycolylneuraminic acid)-ganglioside
UDP + GM2(N-glycolylneuraminic acid)-ganglioside
-
Substrates: best substrate
Products: -
?
UDP-N-acetyl-D-galactosamine + GM3(N-glycolylneuraminic acid)-ganglioside
UDP + GM2(N-glycolylneuraminic acid)-ganglioside
-
Substrates: best substrate
Products: -
?
UDP-N-acetyl-D-galactosamine + GM3(N-glycolylneuraminic acid)-ganglioside
UDP + GM2(N-glycolylneuraminic acid)-ganglioside
-
Substrates: not as effective as GM3(N-acetylneuraminic acid)
Products: -
?
additional information
?
-
-
Substrates: stable expression of enzyme in CHO-Lec8 cells, production of complex-type N-glycans quantitatively bearing LacdiNAc-structures on their antennae and containing repeating LacdiNAc-structures
Products: -
?
additional information
?
-
-
Substrates: carbohydrate-protein conjugate enzyme activity with truncated ceramides, analogues of GM3 and GM2 gangliosides, compound sythesis, overview
Products: -
?
additional information
?
-
-
Substrates: carbohydrate-protein conjugate enzyme activity with truncated ceramides, analogues of GM3 and GM2 gangliosides, compound sythesis, overview
Products: -
?
additional information
?
-
-
Substrates: during evolution, beta4Gal-T1 appears as a result of the single amino acid substitution of Tyr or Phe for Leu or Ile in the invertebrate beta4GalNAc-T1, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme synthesizes the LacdiNAc structures, with GalNAcbeta1,4GlcNAc, on several glycoproteins and glycosphingolipids, including N-glycans, O-glycans, and the arthro-series GSLs, GalNAcbeta1,4Glc-NAcbeta1,3Manbeta1,4Glcbeta1Cer, and neutral GSLs, in vitro and in vivo, the GalNAcbeta1,4GlcNAc, i.e. LacdiNAc or LDN, structure is a more common structural feature in invertebrate glycoconjugates when compared with the Galbeta1,4GlcNAc, i.e. LacNAc or LN, structure
Products: -
?
additional information
?
-
-
Substrates: no activity with donor UDP-galactose, the enzyme synthesizes the LacdiNAc structures, with GalNAcbeta1,4GlcNAc, on several glycoproteins and glycosphingolipids, including N-glycans, O-glycans, and the arthro-series GSLs, such as GalNAcbeta1,4Glc-NAcbeta1,3Manbeta1,4Glcbeta1Cer, and neutral GSLs, in vitro and in vivo
Products: -
?
additional information
?
-
-
Substrates: the wild-type Drosophila beta4GalNAc-T1 enzyme binds to the mammary gland-specific protein alpha-lactalbumin
Products: -
?
additional information
?
-
Substrates: overview on substrate specificity
Products: -
?
additional information
?
-
Substrates: enzyme shows similar specificities for O-and N-glykans. Efficiency of transfer decreases as the number of antennas increases
Products: -
?
additional information
?
-
-
Substrates: during evolution, beta4Gal-T1 appears as a result of the single amino acid substitution of Tyr or Phe for Leu or Ile in the invertebrate beta4GalNAc-T1, overview
Products: -
?
additional information
?
-
-
Substrates: no substrate: lactosylceramide, sialylparagloboside, GM1b(N-glycolylneuraminic acid), GD1a(N-acetylneuraminic acid), GT1b(N-acetylneuraminic acid), GQ1b(N-acetylneuraminic acid), GM1a(N-acetylneuraminic acid), GD1b(N-acetylneuraminic acid), globoside
Products: -
?
additional information
?
-
-
Substrates: poor substrate: sialyllactose
Products: -
?
additional information
?
-
-
Substrates: acceptor specificity
Products: -
?
additional information
?
-
-
Substrates: poor substrate: GM2-, GM1-, GD1b- and GT1-gangliosides and various ceramides
Products: -
?
additional information
?
-
-
Substrates: no substrate: N-acetylglucosamine
Products: -
?
additional information
?
-
-
Substrates: no substrates are SM4-ganglioside, Gb3- and Gb4-ceramide
Products: -
?
additional information
?
-
-
Substrates: no substrate: blood type H glycoprotein, deglucosylated bovine submaxillary mucin, various ceramides
Products: -
?
additional information
?
-
Substrates: no in vitro transfer of substrates other than UDP-N-acetylgalactosamine to synthetic N-glycans
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
UDP-N-acetyl-alpha-D-galactosamine + ganglioside GM3
UDP + ganglioside GM2
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
additional information
?
-
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
Substrates: relative glycosyltransferase levels involved in determining the ganglioside composition of cells
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: model for ganglioside biosynthesis
Products: -
?
UDP-N-acetyl-D-galactosamine + (N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
UDP + N-acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide
-
Substrates: involved in biosynthesis of gangliosides in brain
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM3
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM3
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-(N-acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
UDP + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
-
Substrates: -
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM2
Products: -
?
UDP-N-acetyl-D-galactosamine + 1-O-[O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1-4)-O-[N-acetyl-alpha-neuraminosyl-(2-3)]-O-beta-D-galactopyranosyl-(1-4)-beta-D-glucopyranosyl]-ceramide
?
-
Substrates: ganglioside GM2
Products: -
?
additional information
?
-
-
Substrates: during evolution, beta4Gal-T1 appears as a result of the single amino acid substitution of Tyr or Phe for Leu or Ile in the invertebrate beta4GalNAc-T1, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme synthesizes the LacdiNAc structures, with GalNAcbeta1,4GlcNAc, on several glycoproteins and glycosphingolipids, including N-glycans, O-glycans, and the arthro-series GSLs, GalNAcbeta1,4Glc-NAcbeta1,3Manbeta1,4Glcbeta1Cer, and neutral GSLs, in vitro and in vivo, the GalNAcbeta1,4GlcNAc, i.e. LacdiNAc or LDN, structure is a more common structural feature in invertebrate glycoconjugates when compared with the Galbeta1,4GlcNAc, i.e. LacNAc or LN, structure
Products: -
?
additional information
?
-
-
Substrates: during evolution, beta4Gal-T1 appears as a result of the single amino acid substitution of Tyr or Phe for Leu or Ile in the invertebrate beta4GalNAc-T1, overview
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.